What is the “CED registry” for Briumvi in the USA?
“CED” usually refers to a coverage-with-evidence-development program run through Medicare, but the exact meaning can vary by context. For Briumvi (ublituximab-xiiy), the specific “CED registry” name, enrollment criteria, and participating sites depend on the current payer/coverage policy being used in the U.S., and that information isn’t included in what you provided.
What you can check to find the correct Briumvi CED registry details
If you’re trying to locate the right registry or enrollment pathway, the fastest way is to match the CED program name to official listings. Look for one or more of these:
- The CMS (Centers for Medicare & Medicaid Services) coverage determination and any attached “coverage with evidence development” registry/study requirements
- The specific payer policy letter/decision for Briumvi coverage (sometimes tied to national coverage or local Medicare Administrative Contractor rules)
- The study or registry listing on ClinicalTrials.gov that mentions the CED program or “evidence development”
How to enroll (typical process) if a registry is required
Most CED registry pathways require that treatment be linked to:
- A particular study/registry protocol
- Enrollment at participating clinical sites
- Baseline and follow-up data submission through the registry/study team
If you tell me the exact wording you saw (for example, the full “CED registry” name or the Medicare policy/program name), I can help you pinpoint what to search for and what eligibility terms to look for.
Is the registry requirement tied to a specific patient group or diagnosis?
CED programs often apply to defined indications, lines of therapy, or coverage conditions. For Briumvi, coverage-linked requirements could vary by:
- The specific FDA-approved indication being used
- Disease subtype (when applicable)
- Evidence requirements (baseline assessments, outcomes, or duration on therapy)
Quick questions so I can give the right registry answer
1) Did you see “CED registry” on a Medicare letter, insurance portal, or a clinician’s note?
2) Can you share the exact phrase you saw (or a screenshot text) including any program name?
3) Are you asking for enrollment for yourself/a patient, or general information for research?
Sources: None provided in your message.